IS THE CURE WORTH THE COST? THE DEBATE OVER THE PRICE OF SPECIALTY DRUGS. | PRESENTED BY: AMERICAN ENTERPRISE INSTITUTE

American Enterprise Institute presented a panel discussion around the costs of speciality drugs on September 12, 2016 in Washington D.C.

Panelists included:

Panelists:
Gregg Alton, Gilead
Peter B. Bach, Memorial Sloan Kettering Cancer Center
Scott Gottlieb, AEI
Joshua Ofman, Amgen
Steven Pearson, Institute for Clinical and Economic Review
Tomas J. Philipson, University of Chicago; AEI

To read the full event summary, please visit the American Enterprise Insitute.

Close Menu